In a large cohort study, the Predicting Risk of Cardiovascular Disease Events calculator underestimated overall risk for ...
A culturally and medically tailored meal program reduced hospitalizations among Navajo Nation residents with heart failure, ...
Once-daily oral zasocitinib for moderate to severe plaque psoriasis demonstrated rapid and durable skin clearance and a ...
In a global cohort of people from 15 countries, 7% had coronary plaque despite a coronary artery calcium score of 0, ...
The addition of pembrolizumab to neoadjuvant chemotherapy followed by single-agent adjuvant pembrolizumab improved long-term ...
Results showed patients who undergo arthroscopic rotator cuff repair may experience a reduction in pain and narcotic use with ...
Adults with moderate to severe hidradenitis suppurativa experienced substantial long-term symptom relief and quality of life ...
SYD-101 significantly slowed the progression of myopia in younger children and quick progressors over 36 months, according to ...
In a phase 2 trial, OCU410, a modifier gene therapy for geographic atrophy secondary to dry age-related macular degeneration, ...
Litifilimab was superior to placebo for reducing skin disease activity in cutaneous lupus erythematosus, according to phase 2 ...
Most underage users on social media can see posts promoting celebrity-owned alcohol brands, many of which are not disclosed ...
In stable patients without heart failure, discontinuing beta-blockers 1 year after a heart attack was noninferior to continued use for all-cause death, recurrent MI or HF hospitalization, researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results